title: Natriuretic effect of bufalin in isolated rat kidneys involves activation of the Na+-K+-ATPase-Src kinase pathway.
abstract: Bufadienolides are structurally related to the clinically relevant cardenolides (e.g., digoxin) and are now considered as endogenous steroid hormones. Binding of ouabain to Na(+)-K(+)-ATPase has been associated, in kidney cells, to the activation of the Src kinase pathway and Na(+)-K(+)-ATPase internalization. Nevertheless, whether the activation of this cascade also occurs with other cardiotonic steroids and leads to diuresis and natriuresis in the isolated intact kidney is still unknown. In the present work, we perfused rat kidneys for 120 min with bufalin (1, 3, or 10 μM) and measured its vascular and tubular effects. Thereafter, we probed the effect of 10 μM 3-(4-chlorophenyl)1-(1,1-dimethylethyl)-1H-pyrazolo[3,4-d]pyrimidin-4amine (PP2), a Src family kinase inhibitor, and 1,4-diamino-2,3-dicyano-1,4-bis[2-aminophenylthio] butadiene (UO126), a highly selective inhibitor of both MEK1 and MEK2, on bufalin-induced renal alterations. Bufalin at 3 and 10 μM profoundly increased several parameters of renal function in a time- and/or concentration-dependent fashion. At a concentration that produced similar inhibition of the rat kidney Na(+)-K(+)-ATPase, ouabain had a much smaller diuretic and natriuretic effect. Although bufalin fully inhibited the rat kidney Na(+)-K(+)-ATPase in vitro, its IC(50) (33 ± 1 μM) was threefold higher than the concentration used ex vivo and all its renal effects were blunted by PP2 and UO126. Furthermore, the phosphorylated (activated) ERK1/2 expression was increased after bufalin perfusion and this effect was totally prevented after PP2 pretreatment. The present study shows for the first time the direct diuretic, natriuretic, and kaliuretic effects of bufalin in isolated rat kidney and the relevance of Na(+)-K(+)-ATPase-mediated signal transduction.
authors.affiliation: Laboratório de Farmacologia Bioquímica e Molecular, Instituto de Ciências Biomédicas, Centro de Ciências da Saúde, Av. Carlos Chagas 373, Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ, Brazil.
authors.forename: Francisco J
authors.initials: FJ
authors.lastname: Arnaud-Batista
authors.forename: Graciana T
authors.initials: GT
authors.lastname: Costa
authors.forename: Ilana Mara Barbosa de
authors.initials: IM
authors.lastname: Oliveira
authors.forename: Paula P C
authors.initials: PP
authors.lastname: Costa
authors.forename: Cláudia F
authors.initials: CF
authors.lastname: Santos
authors.forename: Manassés C
authors.initials: MC
authors.lastname: Fonteles
authors.forename: Daniel E
authors.initials: DE
authors.lastname: Uchôa
authors.forename: Edilberto R
authors.initials: ER
authors.lastname: Silveira
authors.forename: Bruno A
authors.initials: BA
authors.lastname: Cardi
authors.forename: Krishnamurti M
authors.initials: KM
authors.lastname: Carvalho
authors.forename: Luciana S
authors.initials: LS
authors.lastname: Amaral
authors.forename: Elisa S C
authors.initials: ES
authors.lastname: Pôças
authors.forename: Luis E M
authors.initials: LE
authors.lastname: Quintas
authors.forename: François
authors.initials: F
authors.lastname: Noël
authors.forename: Nilberto R F
authors.initials: NR
authors.lastname: Nascimento
mesh_terms: D000818:Animals; D002018:Bufanolides / Q000494:pharmacology*; D002070:Butadienes / Q000494:pharmacology; D004231:Diuresis / Q000187:drug effects; D004791:Enzyme Inhibitors / Q000494:pharmacology*; D007668:Kidney / Q000187:drug effects* / Q000201:enzymology; D048369:MAP Kinase Kinase 1 / Q000037:antagonists & inhibitors; D048370:MAP Kinase Kinase 2 / Q000037:antagonists & inhibitors; D008297:Male; D009318:Natriuresis / Q000187:drug effects; D045283:Natriuretic Agents / Q000494:pharmacology*; D009570:Nitriles / Q000494:pharmacology; D010042:Ouabain; D011188:Potassium / Q000652:urine; D011743:Pyrimidines / Q000494:pharmacology; D051381:Rats; D017208:Rats, Wistar; D015398:Signal Transduction / Q000187:drug effects; D000254:Sodium-Potassium-Exchanging ATPase / Q000037:antagonists & inhibitors / Q000378:metabolism*; D019061:src-Family Kinases / Q000037:antagonists & inhibitors / Q000378:metabolism*
chemical_list: C412373:AG 1879; D002018:Bufanolides; D002070:Butadienes; D004791:Enzyme Inhibitors; D045283:Natriuretic Agents; D009570:Nitriles; D011743:Pyrimidines; C113580:U 0126; D010042:Ouabain; D019061:src-Family Kinases; D048369:MAP Kinase Kinase 1; D048370:MAP Kinase Kinase 2; D000254:Sodium-Potassium-Exchanging ATPase; D011188:Potassium; C022777:bufalin